P1.03-005 Phase 2 Study of Ceritinib in Patients with ALK+...

Journal of Thoracic Oncology 2017 / 11 Vol. 12; Iss. 11

P1.03-005 Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9

Horinouchi, H., Maemondo, M., Hida, T., Takeda, M., Hotta, K., Hirai, F., Kim, Y., Matsumoto, S., Mitsudomi, T., Seto, T., Moizumi, S., Tokushige, K., Hatano, B., Nishio, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.809
Date:
November, 2017
File:
PDF, 373 KB
english, 2017
Conversion to is in progress
Conversion to is failed